OnKure Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About OKUR
All events for OKUR
All deals for OKUR
Financial Ratios
Financial Statements
OKUR vs Sector & Peers
About OnKure Therapeutics, Inc.
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations. Website onkuretherapeutics.com
Headquarters Boulder, CO, US